About Us

Mosim is the leading biopharmaceutical services company in China, offering clinical pharmacology, biostatistics, clinical data management, medical writing and clinical operation services. Dr Jiansong Yang, Co-founder and CEO, has ~20 years of experience in modeling and simulation. Prior to setting up Mosim, he was Director of Clinical Pharmacology Modeling & Simulation at GSK (2009-2015) and Principal Scientist at Simcyp (2003-2009). Since its foundation in 2015, Mosim has grown into a team of over 50 staff members. It is headquartered in Zhangjiang Pharma Valley, with branch offices in Nanjing and Beijing. Our clients include the top pharmaceutical and biotechnology companies, both in China and overseas.

The company name 'Mosim' is an abbreviation of 'Modeling & Simulation'. Our core technology is the application of modeling and simulation to guide clinical drug development strategies and optimize the clinical study design. Drug development becomes increasingly expensive and time-consuming. Model-informed drug development (MIDD) is a promising approach to improve decision making in drug development. Modeling and simulation provides a quantitative basis for the trial design, dose selection and clinical decision making at various stages of clinical development.